The randomized controlled clinical trial of the utilization of Red Koji (Red Mold Rice) in dietary therapy for serum lipid improvement - The randomized controlled clinical trial of the utilization of Red Koji (Red Mold Rice) in dietary therapy for serum lipid improvement

Graduate School of Medicine, Chiba University0 个研究点目标入组 32 人开始时间: 2012年4月9日最近更新: 2023年10月17日

试验速览

暂无简介。

•1)Patients with familial hypercholesterolemia or with LDL-cholesterol level of 180 and over mg/dL 2)People with rice allergy, and people who have resistance in eating rice 3)Patients taking statin drugs within 4 weeks (or Probucol within 8 weeks) in the past 4)Patients with type 1 diabetes or diabetic patients with HbA1c level of over 8% 5)Patients with sever diseases other than diabetes, such as liver disease, a renal disease, and cardiac disease 6)Patients with the past, such as a food allergy, idiosyncrasy, and alcoholism 7)People who participated in other clinical trials within the past three months before the start of this clinical trial, or who have participated in other clinical trials at the start of this clinical trial 8)Patients who are pregnant, breastfeeding or intention to becoming pregnant 9)Patients whose LDL-cholesterol level became less than 140 mg/dL by dietary therapy of period I or patients with TG level of 400 and over mg/dL 10)Patients judged unsuitable by the investigator

发起方

Graduate School of Medicine, Chiba University